Watkins Myron MD

Watkins Myron MD, a sole proprietorship owned by Dr. Myron Watkins, provides independent medical case reviews and disability adjudication consulting to the Social Security Administration as a prime contractor under blanket purchase agreements. The firm is registered as a minority-owned, veteran-owned, and Black American-owned business based in Dallas, Texas, and operates exclusively within the medical consultation space (NAICS 6111, Offices of Physicians) under no set-aside designation — all 46 awards in the source represent full-and-open, non-set-aside procurements.

Watkins Myron MD's entire federal footprint centers on a single customer, the Social Security Administration, which accounts for 100% of awards and combined potential value ($5.8 million). The vendor holds three active BPAs with SSA: BPA SS06164C029 (16 task orders, $1.4 million combined potential value), BPA 28321321AC0640009 (15 task orders, $1.1 million combined potential value), and BPA SS061140035 (12 task orders, $648 thousand combined potential value). The primary BPA 28321321AC0640009, awarded July 23, 2021, carries a ceiling of $2.656 million and runs through June 30, 2028; it has generated over $800,000 in call orders since inception. Recent BPA calls demonstrate steady activity: a $215,625 call awarded June 26, 2026, for independent case reviews extending through June 30, 2027; a $148,512 call awarded June 2, 2025, completing June 3, 2026; a $142,942.80 call awarded July 8, 2024, for independent case reviews; and a $106,470 call awarded June 22, 2023, for 2,400 independent case reviews. Work is performed in Dallas, Texas and involves medical documentation review, professional medical opinions evaluating complex disability claims, and non-case consulting hours supporting SSA's disability determination program.

Activity remains consistent with two to three awards per year across 2022 through 2026. Only one award ($216 thousand combined potential value) reaches ultimate completion inside the next twenty-four months, creating minimal near-term recompete exposure. The vendor has obligated $3.2 million of its $5.8 million combined potential value (55% draw rate), indicating moderate utilization velocity across its BPA portfolio. With exclusive SSA focus and single-customer concentration, competitive opportunity is limited to SSA disability adjudication procurements under the named BPAs.